SCHEMBL7974274

SCHEMBL7974274

O=c1[nH]c(-c2ccccc2F)nc2ncn(CCc3ccccc3)c12

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 6/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
KMT2A Q03164 3/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 4/20 0.43
DAO P14920 1/20 0.41
HTT P42858 1/20 0.40
PDE1A P54750 1/20 0.39
PDE1B Q01064 1/20 0.39
PDE1C Q14123 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984463 0.94 KDM4E (0.53) CNOT7SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7974644 0.89 SMN1; SMN2 (0.55) CNOT7SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7974613 0.85 CNOT7 (0.49) CNOT7SMN1; SMN2KMT2AHPGDKDM4E
SCHEMBL7984480 0.85 CNOT7 (0.47) CNOT7SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7973869 0.84 TNKS (0.46) CNOT7SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7985444 0.84 CNOT7 (0.41) CNOT7SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7988183 0.82 SMN1; SMN2 (0.48) SMN1; SMN2KMT2AHPGDMEN1KDM4E
SCHEMBL7974278 0.82 CNOT7 (0.53) CNOT7SMN1; SMN2KMT2AHPGDMEN1
SCHEMBL7973916 0.82 LMNA (0.43) SMN1; SMN2KMT2AHPGDMEN1LMNA
SCHEMBL7988452 0.82 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AHPGDMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed